Medication info

Carbfin Tablet 30/10 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate Granules›75mg / 1 tabletAmlodipine Besylate›13.88mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Pale green apple-shaped film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201603157 · Approved 2016.05.31

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose with fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary in elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment with the fimasartan 30 mg dose of this medicine should be initiated. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is used in patients with essential hypertension when monotherapy is insufficient for blood pressure control. This medication effectively lowers blood pressure and helps reduce the risk of cardiovascular complications. Therefore, it is used in the treatment of essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. If possible, it is recommended to take it at the same time every day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose with fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary in elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment with the fimasartan 30 mg dose of this medicine should be initiated. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.

Precautions

This medication can cause serious harm or death to the fetus and newborn when taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Do not use in patients with hypersensitivity to any component of this medication, those who are pregnant or breastfeeding, patients undergoing renal dialysis, or those with moderate to severe liver impairment, biliary obstruction, certain kidney diseases, or genetic lactose intolerance. Patients with reduced blood volume or salt, impaired kidney function, renovascular hypertension, severe hypotension, elderly patients, and patients with certain heart diseases need special caution when administering this medication. Side effects such as dizziness, headache, edema, urinary disorders, and insomnia may occur while taking this medication, and rarely, serious kidney problems, allergic reactions, or cardiovascular issues may arise. There is a risk of hypotension and electrolyte imbalances, especially hyperkalemia, so regular blood tests should be conducted to monitor the condition. When taken with other antihypertensives, potassium-sparing diuretics, or non-steroidal anti-inflammatory drugs, the risk of side effects may increase due to interactions, so caution should be exercised. Pregnant or breastfeeding individuals should avoid taking this medication, especially during pregnancy as it could pose risks to the fetus, and they should consult a physician. The safety and efficacy in children under the age of 18 have not been established, and elderly patients over 70 years may be more sensitive to the medication. In case of overdose, symptoms such as hypotension, cardiac arrhythmias, or shock may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and not transferred to another container for safety. Drowsiness or dizziness may occur while taking this medication, so driving or operating dangerous machinery should be done with caution.

Side effects

  • Dizziness
  • headache
  • orthostatic dizziness
  • facial swelling
  • peripheral edema
  • urination disorder
  • insomnia
  • syncope
  • sedation
  • migraine
Show 196 more
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzymes
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contractions
  • musculoskeletal stiffness
  • pruritus
  • localized urticaria
  • facial flushing
  • flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colon cancer
  • neoplasm unspecified
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • pulmonary disease
  • death
  • worsening low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • cerebral infarction
  • fracture
  • chest pain
  • carpal tunnel syndrome
  • pulmonary tuberculosis
  • axillary pain
  • periorbital edema
  • allergy
  • chills
  • edema
  • fatigue
  • fever
  • neck/shoulder pain
  • muscle weakness
  • tendinitis
  • osteomyelitis
  • shoulder impingement syndrome
  • lateral epicondylitis
  • synovitis
  • sciatica
  • jaw pain
  • arthralgia
  • osteoporosis
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • nosebleed
  • bronchitis
  • sensory abnormalities
  • numbness
  • tremor
  • hypertonia
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional bowel disorder
  • gastroenteritis
  • frequent urination
  • dysuria
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • tachycardia
  • purpura
  • fatty liver
  • skin flushing
  • papular rash
  • heaviness
  • warmth sensation
  • impaired glucose tolerance
  • weakness
  • flushing
  • fatigue
  • edema
  • palpitations
  • dizziness
  • drowsiness
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain/loss
  • hypotension
  • vasculitis
  • increased tension
  • sensory loss
  • peripheral neuropathy
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • dyspnea
  • rhinitis
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urination frequency
  • urination disorder
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • vascular edema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • skin flushing
  • papular rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is important to store the medication at room temperature, between 1 degree and 30 degrees Celsius, to maintain its effectiveness.

Appearance and packaging

Appearance

Pale green apple-shaped film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.